Literature DB >> 18835648

Preoperative continuous positive airway pressure compliance in children with obstructive sleep apnea syndrome: assessed by a simplified approach.

A Castorena-Maldonado1, L Torre-Bouscoulet, S Meza-Vargas, J C Vázquez-García, E López-Escárcega, R Pérez-Padilla.   

Abstract

INTRODUCTION: The frequency of diagnoses of obstructive sleep apnea syndrome (OSAS) in children is increasing and more and more adenotonsillectomies (A&T) are being performed on severely ill children who have a higher perioperatory risk. The objective of the present study was to describe preoperative compliance in the use of continuous positive airway pressure (CPAP) in children with OSAS, when this treatment was prescribed as a means of preventing complications. PATIENTS AND METHODS: We describe data from children with severe OSAS caused by hypertrophy of the adenoids and tonsils, but with no craniofacial abnormalities. CPAP pressure was adjusted either during diurnal polysomnography with sleep deprivation or by self-adjusting devices. Follow-up was conducted through weekly interviews and the downloading of data recorded by the equipment.
RESULTS: 48 children were included; 73% of them used a CPAP machine > or =3h per night, and 31% used it for > or =6h per night. The variables associated with good equipment compliance included higher BMI, higher pressure levels in the devices, and a higher number of episodes of apneas and hypopneas. Children who weighed > or =30kg used CPAP for > or =3h per night more often (OR 16, 95% CI 1.9-137). Compliance levels with fixed and self-adjusting CPAP were similar, and side effects in both cases were slight and limited to those caused by the pressure of the masks on patients' skin. One case of excessive bleeding was the only complication reported during A&T.
CONCLUSIONS: The mean preoperative use of CPAP equipment by children with severe OSAS was 4.5+/-2.6h. Seventy-three percent of subjects used the equipment for >/=3h.

Entities:  

Mesh:

Year:  2008        PMID: 18835648     DOI: 10.1016/j.ijporl.2008.08.016

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  6 in total

1.  Factors related to positive airway pressure therapy adherence in children with obesity and sleep-disordered breathing.

Authors:  Sherri L Katz; Valerie G Kirk; Joanna E MacLean; Glenda N Bendiak; Mary-Ann Harrison; Nicholas Barrowman; Lynda Hoey; Linda Horwood; Stasia Hadjiyannakis; Laurent Legault; Bethany J Foster; Evelyn Constantin
Journal:  J Clin Sleep Med       Date:  2020-02-07       Impact factor: 4.062

2.  Objective adherence to positive airway pressure therapy in an Australian paediatric cohort.

Authors:  Rita Machaalani; Carla A Evans; Karen A Waters
Journal:  Sleep Breath       Date:  2016-09-03       Impact factor: 2.816

3.  Age and weight considerations for the use of continuous positive airway pressure therapy in pediatric populations: an American Academy of Sleep Medicine position statement.

Authors:  Louella Amos; Olufunke Afolabi-Brown; Dominic Gault; Robin Lloyd; Moshe Y Prero; Carol L Rosen; Raman K Malhotra; Jennifer L Martin; Kannan Ramar; James A Rowley; Fariha Abbasi-Feinberg; R Nisha Aurora; Vishesh K Kapur; Uzma Kazmi; David Kuhlmann; Eric J Olson; Anita V Shelgikar; Sherene M Thomas; Lynn Marie Trotti
Journal:  J Clin Sleep Med       Date:  2022-08-01       Impact factor: 4.324

4.  Sleep endoscopy in the evaluation of pediatric obstructive sleep apnea.

Authors:  Aaron C Lin; Peter J Koltai
Journal:  Int J Pediatr       Date:  2012-02-15

Review 5.  An updated review of pediatric drug-induced sleep endoscopy.

Authors:  Lyndy J Wilcox; Mathieu Bergeron; Saranya Reghunathan; Stacey L Ishman
Journal:  Laryngoscope Investig Otolaryngol       Date:  2017-11-02

Review 6.  Any Effective Intervention to Improve CPAP Adherence in Children with Obstructive Sleep Apnea: A Systematic Review.

Authors:  Bundit Sawunyavisuth; Chetta Ngamjarus; Kittisak Sawanyawisuth
Journal:  Glob Pediatr Health       Date:  2021-05-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.